- Lobbying
- JOHN AND CASSIDY
Lobbying Arrangements Results for 'John Cassidy'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Army/Department of Defense health issues Army and Navy programmatic appropriations |
Strike Photonics
|
Cassidy & Associates, Inc. | |||
Details Prescription drug payment reform. Supply Chain. Strategic National Stockpile. 340B. |
Gilead Sciences, Inc.
|
Todd Strategy Group | |||
Details Promote discussions regarding cooperation between US and China on aviation security policy issues Facilitate interactions with federal agencies regarding qualification process for aviation security... |
Nuctech Company Limited
Security equipment |
Cassidy & Associates, Inc. | |||
Details Advise client on legislative and administrative policy-making related to the bio-pharmaceutical industry generally, and client priorities specifically. Includes FDA and CMS related matters, as well... |
Avanir Pharmaceuticals, Inc.
|
BGR Government Affairs | |||
Details Provide strategic guidance and counsel on potential changes to FDA regulations |
Flexion Therapeutics, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Amarin Pharm Inc. specifically |
Amarin Pharm Inc.
|
BGR Government Affairs | |||
Details Telecommunications contracting in the federal government Network and telecommunications contracting Funding for telecommunications and network programs in the federal government FAA network and tel... |
Verizon
|
Cassidy & Associates, Inc. | |||
Details Issues related to internet governance |
Kalorama Group, LLC
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Extend for an additional 50 years the lease under which the District of Columbia government uses the ground under and parking facilities associated with Robert F. Kennedy Memorial Stadium (H.R. 3373). |
Washington Convention Center Authority/EventsDC
|
Squire Patton Boggs | |||
Details FY23 Consolidated Appropriations & FY23 NDAA |
Pharmaceutical Research and Manufacturers of America (PhRMA)
Trade organization for pharmaceutical research and manufacturers |
Cassidy & Associates, Inc. | |||
Details H.R. 1628 (American Health Care Act of 2017), Senate discussion draft (Better Care Reconciliation Act of 2017) and Graham-Cassidy Substitute Amendment No. 1030 to H.R. 1628, all provisions |
UNIVERSITY OF ARKANSAS MEDICAL SCIENCES
|
Arent Fox LLP | |||
Details Reform of the immigrant investor EB-5 program |
US Immigration Fund LLC
|
Squire Patton Boggs | |||
Details Medicare Rulemaking. |
Vifor Pharma, Inc.
|
Todd Strategy Group | |||
Details Diagnostics coverage and reimbursement. H.R.4128 - VALID Act of 2021. |
Veracyte, Inc.
|
Todd Strategy Group | |||
Details Appropriations. Medicare Coverage and Reimbursement. |
Puerto Rico Financial and Fiscal Authority
|
Todd Strategy Group | |||
Details issues concerning environment, engineering and construction services in the area of water, waste water and environmental remediation issues concerning environment, engineering and construction serv... |
MWH
wet infrastructure engineering firm |
MCAPITOL MANAGEMENT | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation on drug disposal programs. |
DisposeRx, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally, and Nektar Therapeutics specifically. |
Nektar Therapeutics
|
BGR Government Affairs | |||
Details Provide strategic guidance and advocacy on policies and developments impacting device manufacturing, medical imaging and diagnostic tests, and Siemens Healthineers specifically. |
Siemens Healthineers
|
BGR Government Affairs | |||
Details Pandemic and All-Hazards Preparedness Act (PAHPA). Pharmacy Benefit Managers. 340B. Tort litigation reform, Health Care Supply Chain. |
Johnson & Johnson Services, Inc.
Pharmaceutical and medical technologies corporation. |
Todd Strategy Group | |||
Details Provide strategic guidance and advocacy on potential regulations and/or legislation impacting food innovation |
Impossible Foods Inc.
|
BGR Government Affairs | |||
Details Industrial Base Expansion. Pharmaceutical Manufacturing and Supply Chain. |
EMD Millipore
Biochemicals and reagents for life science research and discovery. |
Todd Strategy Group | |||
Details Advise client on legislative and administrative policy-making related to the bio-pharmaceutical industry generally, and client priorities specifically. Includes FDA and CMS related matters, as well... |
Alnylam Pharmaceuticals, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biotechnology industry |
Sanofi US Services, Inc.
|
BGR Government Affairs | |||
Details Providing advice, counsel, and services to support the Pharma & Biopharma Outsourcing Association's public policy priorities |
Pharma & Biopharma Outsourcing Association
|
BGR Government Affairs | |||
Details Medicare coverage for colon cancer screening |
Epigenomics, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Baudax Bio, Inc. specifically. |
Baudax Bio, Inc. (formerly known as Recro Pharma, Inc.)
|
BGR Government Affairs | |||
Details Provide guidance and strategic advice regarding FDA regulation of medical devices, including diagnostic tests |
Advanced Medical Technology Association
|
BGR Government Affairs | |||
Details Strategic guidance and counsel on maintaining and strengthening the employer-based health care system, and advise the client on legislative and regulatory issues. |
Lockton Management, LLC
|
BGR Government Affairs | |||
Details Advise and advocate on client's behalf regarding ongoing public policy concerns impacting the innovative biotechnology industry in Congress and throughout the Administration |
Biotechnology Innovation Organization
|
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the medical device industry generally, and Stryker Corporation specifically. |
Stryker Corporation
|
BGR Government Affairs | |||
Details Advise and advocate on clients behalf regarding ongoing public policy concerns impacting the innovative biopharmaceutical industry in Congress and throughout the Administration. |
Pharmaceutical Research and Manufacturers of America
|
BGR Government Affairs | |||
Details Provide strategic counsel and guidance on issues impacting the clinical services industry generally, and Matrix Medical Network specifically as well as issues relating to MA risk adjustment. |
Matrix Medical Network
|
BGR Government Affairs | |||
Details Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid and FDA |
GlaxoSmithKline, INC
|
BGR Government Affairs | |||
Details Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Ca... |
Amgen Inc.
|
BGR Government Affairs | |||
Details Provide guidance and counsel with regard to federal medical device policy and regulatory issues and reimbursement issues within Medicare program, including IPPS Regulation, and FDA regulatory policy. |
Abiomed Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy |
Neurocrine Biosciences, Inc.
|
BGR Government Affairs | |||
Details Issues related to the chapter 11 case filed by Westinghouse Electric Company |
TOSHIBA CORPORATION
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Medicare Reimbursement for New Technologies. 340B. Home Infusion for Part B Products. H.R.830 - HELP Copays Act. Employee Retirement Income Security Act (ERISA) issues. General issues related to ra... |
Alexion Pharmaceuticals, Inc.
|
Todd Strategy Group | |||
Details Medicare coverage and reimbursement for diagnostics. HR.2369- VALID Act. |
The Coalition for 21st Century Medicine
|
Todd Strategy Group | |||
Details Vaccine access and reimbursement. Recovery of missed routine adult vaccines. Pandemic and All-Hazards Preparedness Act (PAHPA). Issues relating to access and coverage of immunizations. CDC Immuniza... |
Adult Vaccine Access Coalition
|
Todd Strategy Group | |||
Details Organ procurement regulations. Increasing access to organ transplant. |
Southwest Transplant Alliance
Nonprofit organization dedicated to fulfilling the gifts of organ and tissue donation. |
Todd Strategy Group | |||
Details General Discussions related to the Food and Drug Administration's regulation of diagnostics. General health care procurement policy issues. |
Illumina, Inc.
|
Todd Strategy Group | |||
Details Banking Regulatory Reform Issues. |
Truist Financial Corporation
|
Todd Strategy Group | |||
Details Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues |
Eli Lilly & Co, Inc.
|
BGR Government Affairs | |||
Details Industrial base expansion. Vaccine manufacturing. |
AVS Bio
|
Todd Strategy Group | |||
Details Enterprise Infrastructure General Services Administration Solutions contract. |
Granite Telecommunications
|
Squire Patton Boggs | |||
Details Organ procurement policy. |
Organize.org
|
Todd Strategy Group | |||
Details General Medicare/Medicaid Issues. Center for Medicare and Medicaid Innovation. Fraud, waste and abuse in Federal programs. |
Med Claims Compliance Corporation
|
Todd Strategy Group | |||
Details Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's pro... |
Pharmaceutical Printed Literature Association
|
VENN STRATEGIES |